Inspire Small/Mid Cap ETF

Actus Biotechs Chief Medical Officer Sells Company Common Stock

Winston J Churchill Sells Common Stock of Acuity Brands

Amoco Tech CEO Disposes of Common Stock

Castle Biosciences Inc. Announces Superior Performance of Its Product in Predicting Uveal Melanoma Patient Outcomes

Insider at Aker Technologies sold $928,800 worth of shares

Amkor Technology Director Sells Company Common Stock

Aiker Technology Director Sells Common Stock

Baird Upgrades Tandem Diabetes Care Rating to Outperform with a Price Target of $30

BTIG Analyst Reiterates Buy Rating for Arcutis Biotherapeutics

FormFactor Acquires Keystone Photonics to Enhance Silicon Photonics Testing Capabilities

ProPetro's PROPWR unit signs power service contract with Coterra Energy

Fluence and EDF Win Energy Storage Awards

Photronics released FY2025 annual earnings on December 10 Pre-Market EST, actual revenue USD 849.29 M (forecast USD 838.05 M), actual EPS USD 2.28 (forecast USD 1.68)

Photronics released FY2025 Q4 earnings on December 10 Pre-Market (EST), actual revenue USD 215.77 M (forecast USD 204.54 M), actual EPS USD 1.07 (forecast USD 0.445)

iSAM Funds UK Ltd Increases Holdings in Acorn Technologies in Q2

Prudential Financial Cuts Holdings in Harmonix

Castle Biosciences Inc.'s DecisionDx-Melanoma test receives endorsement from melanoma expert panel

Johnson Rice Downgrades Fluence Energy to Hold with a Target Price of $18.00

Fluence Energy UK Launches Second Phase of Battery Storage Project

Fluence Energy's stock price rises by 22%, seven investment firms upgrade target price

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

TNDM

Rosen Law Firm is investigating potential securities claims against Tandem Diabetes Care, Inc. for allegedly issuing misleading business information. The firm is preparing a class action to recover investor losses after Tandem's stock fell 19.9% following a voluntary medical device correction announcement. Investors are encouraged to join the class action for potential compensation.

prnewswire

Tandem Diabetes

18:04 ET
			
			
				Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

ARQT

VP Burnett of Arcutis Biotherapeutics Inc sold 11,500 shares for $332,851, as disclosed in a Form 4 filed with the SEC. The transaction was part of a prearranged trading plan (10b5-1). Ending holdings are 98,307 shares. The Washington Service provides insider trading analysis and data services.

Reuters

Arcutis Biotherapeutics

VP Burnett Sells 11,500 ($332.9K) Of Arcutis Biotherapeutics Inc [ARQT]

Patrick Burnett, Chief Medical Officer of Arcutis Biotherapeutics Inc., reported the sale of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes and not financial advice.

Arcutis Biotherapeutics Chief Medical Officer Patrick Burnett Reports Sale of Common Shares

Hecla Mining's stock surged 261.6% in 2025, driven by strong silver prices and investor interest in precious metals. Despite optimism, Hecla is undervalued by 54.1% based on DCF analysis, but overvalued with a PE ratio of 64.15x compared to a fair ratio of 28.94x. Investors are encouraged to consider narratives for a deeper understanding of its valuation.

Simplywall

Hecla Mining

Is It Too Late to Consider Hecla Mining After Its 262% Surge in 2025?

David C. Sienko, Vice President of Hecla Mining Co, filed a Form 144 with the SEC to sell 207,553 shares of restricted stock on December 17, 2025. This filing allows the sale within 90 days. The Washington Service provides insider trading analysis and data services.

VP Sienko Files To Sell 207,553 Of Hecla Mining Co [HL]

Gold trading above $4,300 per ounce has led to a global drilling boom, with companies like GoldHaven Resources, Omai Gold Mines, Fortuna Mining, Coeur Mining, and Hecla Mining expanding exploration programs. Morgan Stanley revised its 2026 gold forecast to $4,400 per ounce. GoldHaven's inaugural diamond drilling at Copeçal Gold Project in Brazil intersected potential gold and copper mineralization, suggesting a substantial mineralized system. The company is also advancing projects in British Columbia. Omai Gold Mines reported high-grade drilling results from its Omai Gold Project in Guyana.

ETFS Capital Ltd.

Fortuna Silver Mines

11:55 ET
			
			
				The Race for Resources: $4,300 Gold Triggers Aggressive Global Drilling Frenzy

Shares of U.S. silver miners rose premarket as silver prices surged past $65 per ounce, driven by soft U.S. jobs data and expectations of future rate cuts. Hecla Mining and Coeur Mining saw increases of 2.2% and 2%, respectively. Canadian miners Endeavour Silver and Silvercorp Metals also gained. The largest silver-backed ETF, iShares Silver Trust, rose 3.4%, while Global X Silver Miners and Proshares Ultra Silver increased by 1.9% and 6.7%, respectively.

Endeavour Silver

Coeur Mining

BUZZ-Silver miners gain as precious metal soars to new peak

BTIG analyst Kambiz Yazdi reiterated a Buy rating on Arcutis Biotherapeutics with a $31.00 price target. Yazdi, who covers the Healthcare sector, has a 48.4% average return and a 76.92% success rate on recommended stocks. The general analyst consensus for Arcutis Biotherapeutics is a Strong Buy with a $29.71 average price target.

Tip Ranks

BTIG Remains a Buy on Arcutis Biotherapeutics (ARQT)

JKHY

TRMB

Top Wall Street analysts upgraded several stocks, including Jack Henry & Associates, Trimble Inc, Tandem Diabetes Care, ServiceNow Inc, and Rockwell Automation. RBC Capital raised Jack Henry's target to $210, Keybanc set Trimble's target at $99, Baird increased Tandem's target to $30, Guggenheim upgraded ServiceNow to Neutral, and Goldman Sachs raised Rockwell's target to $448.

benzinga_article

Jack Henry & Associates

ServiceNow

Trimble

This Rockwell Automation Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Shares of U.S.-listed silver miners fell premarket, tracking a 1.4% drop in spot silver prices to $63.03/ounce. This decline follows a record high of $64.65 and comes as investors grow cautious ahead of key U.S. jobs and inflation data. Hecla Mining and Coeur Mining saw declines of 1.4% and ~2%, respectively, while Canadian miners Endeavour Silver and Silvercorp Metals also fell. ETFs Abrdn Physical Silver Shares and iShares Silver Trust both dropped ~2%.

Silvercorp Met

BUZZ-Silver miners fall as investors turn wary ahead of year-end US data

Joseph Reagor from Roth MKM maintained a Sell rating on Hecla Mining Company with a price target of $12.00. Reagor, who covers the Basic Materials sector, has an average return of 24.8% and a 54.33% success rate on recommended stocks. Hecla Mining Company has an analyst consensus of Hold with a price target consensus of $15.42.

Hecla Mining Company (HL) Gets a Sell from Roth MKM

Hecla Mining Co's short interest has risen by 3.15%, with 27.47 million shares sold short, representing 4.58% of available shares. It would take traders 1.74 days to cover these positions. The increase in short interest suggests bearish market sentiment compared to peers, where the average short interest is 3.22%. This could indicate potential stock price movements.

What Does the Market Think About Hecla Mining Co?

FRMI

LENZ

OKLO

SNDK

NXDR

RCUS

ALAB

FLNC

Fermi(FRMI) fell 33.84%, with a trading turnover 602.5 Million USD, and a year-to-date fell 52%. LENZ Therapeutics(LENZ) fell 25.96%, with a trading turnover 123.8 Million USD, and a year-to-date fell 37.2%. Modine Manufacturing(MOD) fell 15.32%, with a trading turnover 324.8 Million USD, and a year-to-date rose 20.7%.

18:04 ET Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM

VP Burnett Sells 11,500 ($332.9K) Of Arcutis Biotherapeutics Inc [ARQT]

Arcutis Biotherapeutics Chief Medical Officer Patrick Burnett Reports Sale of Common Shares

Is It Too Late to Consider Hecla Mining After Its 262% Surge in 2025?

VP Sienko Files To Sell 207,553 Of Hecla Mining Co [HL]